Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Prophylaxis”

627 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 627 results

Testing effectiveness (Phase 2)Temporarily pausedNCT05672355
What this trial is testing

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaCOVID-19 Infection
City of Hope Medical Center 80
Large-scale testing (Phase 3)Study completedNCT03116594
What this trial is testing

Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Who this might be right for
Herpes Zoster
SK Chemicals Co., Ltd. 675
Early research (Phase 1)Study completedNCT00136331
What this trial is testing

Study of a Pandemic Influenza Vaccine

Who this might be right for
Influenza
Seqirus 400
Large-scale testing (Phase 3)Study completedNCT03493542
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Who this might be right for
Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
Merck Sharp & Dohme LLC 766
Large-scale testing (Phase 3)Study completedNCT02193061
What this trial is testing

Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs

Who this might be right for
Rotavirus Vaccine
National Institute of Pediatrics, Mexico 1,498
Not applicableNot Yet RecruitingNCT07591181
What this trial is testing

A Study on the Immunization Schedule for the 13-Valent Pneumococcal Polysaccharide-Conjugate Vaccine in Healthy Infants

Who this might be right for
Pneumococcal Disease Prevention
Beijing Center for Disease Control and Prevention 210
Testing effectiveness (Phase 2)Study completedNCT00601731
What this trial is testing

Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months

Who this might be right for
Meningococcal Disease
Novartis Vaccines 382
Testing effectiveness (Phase 2)Study completedNCT00498654
What this trial is testing

Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects

Who this might be right for
Typhoid Fever
Avant Immunotherapeutics 180
Testing effectiveness (Phase 2)Looking for participantsNCT07207408
What this trial is testing

Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

Who this might be right for
Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis
Dynavax Technologies Corporation 148
Early research (Phase 1)Study completedNCT01302990
What this trial is testing

Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults

Who this might be right for
Flu
Medicago 100
Post-approval studies (Phase 4)Study completedNCT02991872
What this trial is testing

Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children

Who this might be right for
Virus Diseases
GlaxoSmithKline 150
Very early researchStudy completedNCT06541093
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.

Who this might be right for
AIDS/HIV - RelatedDisease Associated With AIDSVaccine-Preventable DiseasesHIV Infections
Uvax Bio LLC 34
Early research (Phase 1)Study completedNCT00309647
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 400
Early research (Phase 1)Study completedNCT03682107
What this trial is testing

Andes Virus DNA Vaccine for the Prevention of Hantavirus Pulmonary Syndrome Using the PharmaJet Stratis(R) Needle-Free Injection Delivery Device

Who this might be right for
Hantavirus Pulmonary InfectionImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT00535236
What this trial is testing

An Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)

Who this might be right for
Herpes ZosterHerpes Zoster-related Complications
Merck Sharp & Dohme LLC 341
Large-scale testing (Phase 3)UnknownNCT06068556
What this trial is testing

Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition)

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 50
Not applicableUnknownNCT00944879
What this trial is testing

Preparing for Adolescent HIV Vaccine Trials in South Africa:

Who this might be right for
HIV InfectionHIV Infections
Desmond Tutu HIV Centre 1,400
Large-scale testing (Phase 3)Study completedNCT00127010
What this trial is testing

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Who this might be right for
MeaslesRubellaMumps+1 more
GlaxoSmithKline
Large-scale testing (Phase 3)UnknownNCT04640233
What this trial is testing

Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection

Who this might be right for
COVID-19 Prevention
Dr. Reddy's Laboratories Limited 1,600
Large-scale testing (Phase 3)Study completedNCT00784784
What this trial is testing

Zanamivir Versus Trivalent Split Virus Influenza Vaccine

Who this might be right for
Influenza
Mount Sinai Hospital, Canada 64
Load More Results